Skip to main content
NVST
NYSE Life Sciences

Envista Crushes Q1 Estimates with 14% Sales Growth, Unveils New $300M Share Repurchase

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$28.92
Mkt Cap
$4.412B
52W Low
$16.32
52W High
$30.42
52W Position info
77% above low
Off High info
4.9% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

NVST sits 77% above its 52-week low of $16.32.

Summary

Envista Holdings Corp reported robust first-quarter results, with sales rising 14% year-over-year to $705.50 million, significantly beating analyst estimates of $680.05 million. Adjusted diluted EPS also saw a substantial 50% year-over-year increase to $0.36. Further bolstering investor confidence, the company announced a new $300 million share repurchase program. This follows a previous $166 million stock repurchase program mentioned in the 2025 10-K, signaling a continued commitment to shareholder returns. The strong operational performance, evidenced by segment growth across all major businesses, combined with a material capital allocation initiative (the new buyback represents approximately 6.8% of the company's market cap), provides a significant positive catalyst for the stock. Traders will be watching for sustained growth and the execution of the repurchase program.

At the time of this announcement, NVST was trading at $28.92 on NYSE in the Life Sciences sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $16.32 to $30.42. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

NVST - Latest Insights

NVST
Nov 04, 2026, 4:20 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $26.01 info
Change: -$1.18 (-4%) info
Market Cap: $4.009B info
NVST
Nov 04, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $26.01 info
Change: -$1.18 (-4%) info
Market Cap: $4.009B info
NVST
Nov 04, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $26.01 info
Change: -$1.18 (-4%) info
Market Cap: $4.009B info
NVST
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $27.26
Real-time Price: $26.01 info
Change: -$1.25 (-5%) info
Market Cap: $4.009B info
NVST
Aug 05, 2026, 4:40 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.90
Real-time Price: $26.01 info
Change: -$0.890 (-3%) info
Market Cap: $4.009B info